Hope, Progress and the Power of Prevention

Publish Year : 2017
Publisher : International Partnership for Microbicides

Description :

The International Partnership for Microbicides' (IPM) 2016 Annual Report looks back at their monthly dapivirine ring to be the first microbicide and long-acting product to reduce women's risk of HIV in two Phase III trials. The report highlights the dapivirine ring and other milestones to add new tools to women's HIV prevention options. 



Recent Resource

Exploring Factors Associated with ART Adherence and Retention in Care under Option B+ Strategy in Malawi: A Qualitative Study

This qualitative study examines women's experiences with antiretroviral therapy (ART) adherence and...

Joint United Nations Statement on Ending Discrimination in Health Care Settings

The Joint Statement on Ending Discrimination in Health Care Settings, signed by twelve United...

Global Accelerated Action for the Health of Adolescents (AA-HA!): Guidance to Support Country Implementation

Adolescents are one sixth of the world's population and account for 6% of the world's global burden...

View More